Utah Medical Products Inc (UTMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While technical indicators show bullish momentum, the overbought RSI and lack of positive catalysts, combined with declining financial performance, suggest caution. The stock may not align with the user's preference for long-term growth opportunities.
The stock shows bullish momentum with MACD positively expanding and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, RSI at 85.854 indicates an overbought condition, suggesting a potential pullback. Key resistance levels are R1: 68.689 and R2: 70.466, with support at S1: 62.936 and S2: 61.159.
Bullish technical indicators such as MACD and moving averages. Gross margin slightly improved YoY.
RSI indicates overbought conditions. Financial performance shows YoY declines in revenue (-1.23%), net income (-11.58%), and EPS (-6.98%). No recent news or significant trading trends. Stock trend analysis predicts a potential decline in the short term (-0.52% next day, -1.14% next week, -2.24% next month).
In Q4 2025, revenue dropped to $9,045,000 (-1.23% YoY), net income fell to $2,566,000 (-11.58% YoY), and EPS declined to 0.8 (-6.98% YoY). Gross margin slightly increased to 58.2% (+0.14% YoY).
No recent analyst ratings or price target updates available.
